Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
{
"resourceType" : "ArtifactAssessment",
"id" : "385882",
"meta" : {
"versionId" : "11",
"lastUpdated" : "2025-08-14T17:38:12.311Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-rating"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Title: </b>Recommendation Rating: ADA Obesity Management Recommendation 8.16</p><br/><p><b>Rating for Recommendation: </b>Recommendation: ADA Obesity Management Recommendation 8.16</p><br/><table><tr><th>Concept</th><th>Summary</th><th>Rating</th></tr><tr><td>Rating System (coded as: rating-system from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>ADA Level of Evidence</td></tr><tr><td>Direction of Recommendation (coded as: direction-of-recommendation from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>Favors intervention (coded as: RJCS-2021 from https://fevir.net/resources/CodeSystem/27834)</td></tr><tr><td>Ratings (coded as: ratings from https://fevir.net/resources/CodeSystem/179423)</td><td>undefined</td><td>A</td></tr><tr><td>Certainty of Evidence (coded as: certainty-of-evidence from https://fevir.net/resources/CodeSystem/179423)</td><td>A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.</td><td>ADA Level of Evidence A</td></tr></table><br/></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
"valueMarkdown" : "An example using the ArtifactAssessment Resource for representation of the rating assigned to a recommendation."
},
{
"extension" : [
{
"url" : "type",
"valueCode" : "derived-from"
},
{
"url" : "targetReference",
"valueReference" : {
🔗 "reference" : "ArtifactAssessment/179469",
"type" : "ArtifactAssessment",
"display" : "Justification for Recommendation: ADA Obesity Management Recommendation 8.16"
}
}
],
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to"
}
],
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "385882",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"title" : "Recommendation Rating: ADA Obesity Management Recommendation 8.16",
"citeAs" : "Recommendation Rating: ADA Obesity Management Recommendation 8.16 [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 385882. Revised 2025-08-14. Available at: https://fevir.net/resources/ArtifactAssessment/385882. Computable resource at: https://fevir.net/resources/ArtifactAssessment/385882#json.",
"artifactReference" : {
🔗 "reference" : "Composition/179466",
"type" : "Composition",
"display" : "Recommendation: ADA Obesity Management Recommendation 8.16"
},
"content" : [
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "rating-system",
"display" : "Rating System"
}
]
},
"classifier" : [
{
"text" : "ADA Level of Evidence"
}
],
"freeToShare" : true
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "strength-of-recommendation",
"display" : "Strength of Recommendation"
}
]
},
"freeToShare" : true
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "direction-of-recommendation",
"display" : "Direction of Recommendation"
}
]
},
"classifier" : [
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/27834",
"code" : "RJCS-2021",
"display" : "Favors intervention"
}
]
}
],
"freeToShare" : true
},
{
"summary" : "A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"classifier" : [
{
"text" : "ADA Level of Evidence A"
}
],
"freeToShare" : true
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "ratings",
"display" : "Ratings"
}
]
},
"classifier" : [
{
"text" : "A"
}
],
"freeToShare" : true
}
]
}